Sources | Names Used |
---|---|
CTRPv2 | Compound 7d-cis |
PharmacoGx | Compound 7d-cis |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NUP37 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
mRNA | RUNDC3A | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
mRNA | TMEM201 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
mRNA | CBLN1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | C20orf24 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
mRNA | TALDO1 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | POU2F1 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
mRNA | ZSCAN25 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
mRNA | MAP3K19 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |